Chandy; K. George

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chandy; K. George.The latest application filed is for "analogs of shk toxin and their uses in selective inhibition of kv1. 3 potassium channels".

Company Profile

0.11.8

Chandy; K. George - Laguna Beach CA
Chandy; K. George - Irvine CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels Grant 9,878,006 - Chandy , et al. January 30, 2	2018-01-30
Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1. 3 Potassium Channels App 20170274047 - Chandy; K. George ; et al.	2017-09-28
Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels Grant 9,616,102 - Chandy , et al. April 11, 2	2017-04-11
Treatment of Obesity and Obesity-Related Disorders by Pharmalogical Targeting of Kv 1.3 Potassium Channels App 20170095530 - Chandy; K. George ; et al.	2017-04-06
Analogs of ShK Toxin and Their Uses in Selective Inhibition of Kv1.3 Potassium Channels App 20160015782 - Chandy; K. George ; et al.	2016-01-21
Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels Grant 9,061,071 - Chandy , et al. June 23, 2	2015-06-23
Treatment of Obesity and Obesity-Related Disorders by Pharmalogical Targeting of Kv 1.3 Potassium Channels App 20150072940 - Chandy; K. George ; et al.	2015-03-12
Methods for inhibiting neoproliferative changes in blood vessel walls Grant 8,026,263 - Koehler , et al. September 27, 2	2011-09-27
Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells Grant 7,772,408 - Vennekamp , et al. August 10, 2	2010-08-10
Compounds, Methods And Devices for Inhibiting Neoproliferative Changes in Blood Vessel Walls App 20090048270 - Koehler; Ralf ; et al.	2009-02-19
hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target Grant 7,378,496 - Chandy , et al. May 27, 2	2008-05-27
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto App 20070293554 - Chandy; K. George ; et al.	2007-12-20
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto Grant 7,235,577 - Chandy , et al. June 26, 2	2007-06-26
Exons of the hSKCa3/KCNN3 gene Grant 7,022,480 - Gargus , et al. April 4, 2	2006-04-04
SK3-1B GFP transgenic mouse model for spinocerebellar ataxia and hyperexcitable behavior App 20050010967 - Shakkottai, Vikram ; et al.	2005-01-13
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto Grant 6,803,375 - Chandy , et al. October 12, 2	2004-10-12
hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target App 20040137487 - Chandy, K. George ; et al.	2004-07-15
hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and therapeutic target Grant 6,653,100 - Chandy , et al. November 25, 2	2003-11-25
ShK toxin compositions and methods of use Grant 6,077,680 - Kem , et al. June 20, 2	2000-06-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.